2020
|
Invention
|
Therapies for hematologic malignancies.
The invention provides methods that relate to a novel th... |
2017
|
Invention
|
Process methods for phosphatidylinositol 3-kinase inhibitors. A process for the synthesis of quin... |
|
Invention
|
Polymorphic forms of a hydrochloride salt of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phen... |
2016
|
Invention
|
Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof. A proce... |
|
Invention
|
Therapies for hematologic malignancies. The invention provides methods that relate to a novel the... |
|
Invention
|
Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one. ... |
|
Invention
|
Combination therapies for hematologic malignancies.
The invention provides methods that relate t... |
2015
|
Invention
|
Phosphatidylinositol 3-kinase inhibitors.
The present disclosure provides phosphatidylinositol 3... |
|
Invention
|
Phosphatidylinositol 3-kinase inhibitors. The present disclosure provides phosphatidylinositol 3-... |
2014
|
Invention
|
Process methods for phosphatidylinositol 3-kinase inhibitors. A process for the synthesis o... |
|
Invention
|
Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phen... |
2013
|
Invention
|
Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors. The p... |
|
Invention
|
Isoquinolinone or quinazolinone phosphatidylinositol 3-kinase inhibitors. The present disclosure ... |
|
Invention
|
Methods of treatment for solid tumors.
The invention provides methods that relate to a novel the... |
|
Invention
|
Combination therapies for treating cancer. Provided herein are methods that relate to a novel the... |
|
Invention
|
Therapies for treating cancer.
Provided herein are methods that relate to a novel therapeutic st... |
|
Invention
|
H)-one. Polymorphs of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one,... |
|
Invention
|
Compositions and methods of treating a disease with (s)-4 amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,... |
2012
|
Invention
|
Compositions and methods of treating a proliferative disease with a quinazolinone derivative.
Pr... |
|
Invention
|
Compositions and methods of treating a proliferative disease with a quinazolinone derivative. Pro... |
|
Invention
|
Novel quinoxaline inhibitors of pi3k.
The invention provides methods that relate to a novel ther... |
|
Invention
|
Novel quinoxaline inhibitors of pi3k. The invention provides methods that relate to a novel thera... |
|
Invention
|
Combination therapies for hematologic malignancies. The invention provides methods that relate to... |
2011
|
Invention
|
Atropisomers of p13k-inhibiting compounds.
The invention provides compounds, compositions and me... |
|
Invention
|
Atropisomers of pi3k-inhibiting compounds. The invention provides compounds, compositions and met... |
|
Invention
|
Methods of treating hematological disorders with quinazolinone compounds in selected patients. Th... |
2010
|
Invention
|
Treatment of liver disorders with pi3k inhibitors. The invention provides methods to treat certai... |
|
Invention
|
Methods of treatment for solid tumors. The invention provides methods that relate to a novel ther... |